Anima Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Takeda Pharmaceutical has a beta […]

/PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating central nervous...

Reports Full-Year Diluted EPS of $6.63 on a GAAP Basis, an Increase of 2.8 Percent; Adjusted Diluted EPS of $13.77, an Increase of 16.4 Percent; These Results...

The growth of the Huntington's disease market is expected to be mainly driven by less competitive scenarios, entry of innovative emerging therapies, rising prevalence, and geriatric population

/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Huntington's...